Helicobacter Pylori, Helicobacter Pylori Dna
Generic Name: helicobacter pylori, helicobacter pylori dna
Dosage form: LIQUID. Active ingredients: HELICOBACTER PYLORI (10 [hp_M]/mL); HELICOBACTER PYLORI DNA (10 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HELICOBACTER PYLORI (10 [hp_M]/mL); HELICOBACTER PYLORI DNA (10 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Baptisia Tinctoria, Echinacea (angustifolia), Arsenicum Album, Belladonna, Crotalus Horridus, Hyoscyamus Niger, Lachesis Mutus, Pyrogenium, Tarentula Cubensis, Anthracinum
baptisia tinctoria, echinacea (angustifolia), arsenicum album, belladonna, crotalus horridus, hyoscyamus niger, lachesis mutus, pyrogenium, tarentula cubensis, anthracinum
PURPOSE: May temporarily relieve redness, swelling, pus, offensive discharges, fever, muscular soreness, swollen lymph nodes, and burning/stinging pain, bites, and wounds.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Durvalumab
durvalumab
Programmed Death Ligand-1 Blocker [EPC]
11 DESCRIPTION Durvalumab is a programmed cell death ligand 1 (PD-L1) blocking antibody. Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that is produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture. IMFINZI (durvalumab) Injection for intravenous use is a sterile, preservative-free, clear to opalescent, colorless to slightly yellow solution, free from visible particles.
Avobenzone 3%, Homosalate 10%, Octocrylene 6%
avobenzone 3%, homosalate 10%, octocrylene 6%
Sunscreen
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.